Dr.manjunath Associate professor SSMC Tumkur History • 1961 - thalidomide disaster • 1968 – WHO pilot research project for international drug monitoring • 1971 –…

Slide 1FIRST ASEAN – CHINA CONFERENCE ON COMBATING COUNTERFEIT MEDICINAL PRODUCTS JAKARTA, 13-15 NOVEMBER 07 COUNTRY PRESENTATION CAMBODIA Presented by Dr. Chhieng Phana…

Slide 1Counterfeit and Substandard medicine in Laos Report country Slide 2 General situation Areas –Area: 236,800 sq. km. –Capital: Vientiane Border –China, Burma,…

Slide 1Promoting patient-centred healthcare around the world IAPO, AFA, Concebir, Esperantra and fipan are pleased to welcome you to a workshop on: Patient-Centred Healthcare…

1. Denis Kibira/Patrick Mubangizi HEPS Uganda/HAI-Afica Access to Medicines 2. Objectives of presentation To understand What is meant by Essential Medicines Components of…

1. How Have American Patients Been Impacted by Unsafe Medicines? Patient Risk, 2010 - 2013#fakedrugs #PSM2013 2. The Problem of Misbranded Treatments ●The United States…

1. 235 © World Health Organization WHO Technical Report Series, No. 957, 2010 Annex 5 WHO good distribution practices for pharmaceutical products 1. Introduction 2. Scope…

Regional Framework for Action on Access to Essential Medicines in the Western Pacific (2011–2016) Western Paci�c Region WHO Library Cataloguing in Publication Data Regional…

Slide 1Counterfeiting past, present… and future Tim Phillips Slide 2 Slide 3 Past Slide 4 Slide 5 Present Slide 6 Slide 7 Revenues of Knockoff Inc. ($bn) x100 Slide 8 Slide…

Slide 1The Emergence of Anti-Counterfeiting Legislation in East Africa: Implications for Generic Supply and Treatment Access Mandeep Dhaliwal Tenu Avafia With assistance…